We Think Destiny Pharma (LON:DEST) Needs To Drive Business Growth Carefully
May 26
U.K. (FTSE) Biotech Industry Analysis
UpdatedMay 29, 2023
DataAggregated Company Financials
Companies34
- 7D-1.1%
- 3M-13.6%
- 1Y-17.1%
- YTD-19.2%
Over the last 7 days, the Biotech industry has remained flat, although notably PureTech Health gained 6.4%. As for the longer term, the industry has declined 17% in the last year. As for the next few years, earnings are expected to grow by 24% per annum.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 May 2023 | UK£7.0b | UK£1.3b | -UK£205,061,887.00 | 23.3x | -34x | 5.5x |
| Thu, 27 Apr 2023 | UK£7.1b | UK£1.3b | -UK£186,168,233.00 | 23.6x | -38.1x | 5.6x |
| Sat, 25 Mar 2023 | UK£7.2b | UK£1.2b | -UK£155,780,060.00 | 25.3x | -46.3x | 5.8x |
| Mon, 20 Feb 2023 | UK£7.5b | UK£1.2b | -UK£150,009,082.00 | 27.4x | -49.7x | 6.4x |
| Wed, 18 Jan 2023 | UK£7.7b | UK£1.2b | -UK£140,658,681.00 | 28.1x | -55.1x | 6.7x |
| Fri, 16 Dec 2022 | UK£7.4b | UK£1.2b | -UK£137,433,972.00 | 25x | -54x | 6.4x |
| Sun, 13 Nov 2022 | UK£7.9b | UK£1.2b | -UK£140,723,058.00 | 24.1x | -56.1x | 6.8x |
| Tue, 11 Oct 2022 | UK£521.8b | UK£1.2b | -UK£151,210,669.00 | 26.4x | -3450.8x | 448.8x |
| Thu, 08 Sep 2022 | UK£7.0b | UK£1.1b | -UK£146,825,946.00 | 33.6x | -47.7x | 6.3x |
| Sat, 06 Aug 2022 | UK£7.3b | UK£1.1b | -UK£201,439,580.00 | 37.6x | -36.4x | 6.6x |
| Mon, 04 Jul 2022 | UK£7.0b | UK£1.1b | -UK£175,260,183.00 | 36.1x | -39.7x | 6.2x |
| Wed, 01 Jun 2022 | UK£7.2b | UK£1.1b | -UK£152,404,084.00 | 38.8x | -47.2x | 6.5x |
| Fri, 29 Apr 2022 | UK£7.3b | UK£1.1b | -UK£139,739,194.00 | 36.1x | -52.5x | 6.6x |
| Sun, 27 Mar 2022 | UK£7.2b | UK£1.1b | -UK£81,219,245.00 | 40.9x | -89.3x | 6.6x |
| Tue, 22 Feb 2022 | UK£7.7b | UK£1.1b | -UK£119,714,746.00 | 32.6x | -64.4x | 7.1x |
| Thu, 20 Jan 2022 | UK£9.6b | UK£1.1b | -UK£123,352,664.00 | 45.3x | -77.8x | 8.8x |
| Sat, 18 Dec 2021 | UK£11.0b | UK£1.1b | -UK£121,081,863.00 | 49.7x | -90.6x | 10.1x |
| Mon, 15 Nov 2021 | UK£12.0b | UK£1.1b | -UK£149,827,014.00 | 69.8x | -80.1x | 11.1x |
| Wed, 13 Oct 2021 | UK£11.8b | UK£1.1b | -UK£148,535,266.00 | 68.1x | -79.5x | 10.7x |
| Fri, 10 Sep 2021 | UK£12.5b | UK£1.1b | -UK£143,503,184.62 | 52.8x | -86.9x | 11.8x |
| Sun, 08 Aug 2021 | UK£12.1b | UK£1.0b | -UK£172,541,949.91 | 29.9x | -70.3x | 11.9x |
| Sat, 01 May 2021 | UK£11.5b | UK£1.0b | -UK£166,311,048.52 | 30.3x | -69.3x | 11.4x |
| Tue, 02 Feb 2021 | UK£10.8b | UK£1.0b | -UK£143,994,708.81 | 33.3x | -74.8x | 10.7x |
| Fri, 06 Nov 2020 | UK£9.0b | UK£985.1m | -UK£119,804,987.81 | 60x | -75.1x | 9.1x |
| Mon, 10 Aug 2020 | UK£8.2b | UK£992.8m | -UK£138,646,257.45 | 54.3x | -59.1x | 8.3x |
Price to Earnings Ratio
-70x
Current Industry PE
- Investors are pessimistic on the British Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.9x is higher than the industry's current PS ratio of 5.5x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 8.5% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does U.K. Biotech compare with similar industries?
| GB Market | -1.84% | |
| Healthcare | -2.14% | |
| Biotech | -1.12% | |
| Biotech | -1.12% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PRTC PureTech Health | UK£2.25 | 6.4% +UK£37.2m | 21.2% | PS49.3x | |
| ETX e-therapeutics | UK£0.17 | 36.2% +UK£26.4m | -14.8% | PS208.8x | |
| BVXP Bioventix | UK£37.50 | 1.4% +UK£2.8m | 0.4% | PE23.3x | |
| BSFA BSF Enterprise | UK£0.16 | 18.9% +UK£2.6m | 90.9% | PB4.5x | |
| 4BB 4basebio | UK£5.65 | 1.8% +UK£1.2m | 18.9% | PS259.7x |
